Amsurg Corp. (AMSG) Receives “Positive” Rating from KeyCorp
A number of other analysts have also weighed in on AMSG. Wells Fargo & Co. started coverage on shares of Amsurg Corp. in a research note on Tuesday, June 14th. They issued a market perform rating for the company. Bank of America Corp. raised shares of Amsurg Corp. from a neutral rating to a buy rating and set a $104.00 price objective for the company in a research note on Thursday, June 16th. Citigroup Inc. lowered shares of Amsurg Corp. from a buy rating to a neutral rating in a research note on Thursday, June 16th. Robert W. Baird reaffirmed a buy rating on shares of Amsurg Corp. in a research note on Thursday, June 16th. Finally, Goldman Sachs Group Inc. reaffirmed a buy rating on shares of Amsurg Corp. in a research note on Friday, June 17th. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Amsurg Corp. has a consensus rating of Buy and an average price target of $92.09.
Shares of Amsurg Corp. (NASDAQ:AMSG) traded up 1.20% during mid-day trading on Tuesday, hitting $66.58. 279,181 shares of the stock were exchanged. The stock has a market cap of $3.58 billion, a PE ratio of 19.76 and a beta of 0.68. Amsurg Corp. has a 12 month low of $58.37 and a 12 month high of $87.29. The stock’s 50 day moving average is $65.43 and its 200-day moving average is $73.44.
Amsurg Corp. (NASDAQ:AMSG) last released its quarterly earnings data on Tuesday, August 2nd. The company reported $1.10 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.02. Amsurg Corp. had a net margin of 6.53% and a return on equity of 8.20%. The company earned $758.50 million during the quarter, compared to analyst estimates of $769.88 million. During the same period in the prior year, the firm earned $0.97 earnings per share. The firm’s revenue for the quarter was up 21.5% compared to the same quarter last year. On average, analysts anticipate that Amsurg Corp. will post $4.33 EPS for the current year.
In other news, insider Robert Jon Coward sold 7,500 shares of the stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $63.65, for a total transaction of $477,375.00. Following the transaction, the insider now owns 97,507 shares in the company, valued at approximately $6,206,320.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 2.30% of the company’s stock.
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Vaughan Nelson Investment Management L.P. raised its position in shares of Amsurg Corp. by 8.6% in the second quarter. Vaughan Nelson Investment Management L.P. now owns 1,905,818 shares of the company’s stock worth $147,778,000 after buying an additional 150,975 shares during the period. State Street Corp raised its position in shares of Amsurg Corp. by 3.9% in the first quarter. State Street Corp now owns 1,821,003 shares of the company’s stock worth $135,849,000 after buying an additional 68,181 shares during the period. BlackRock Institutional Trust Company N.A. raised its position in shares of Amsurg Corp. by 2.5% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 1,588,313 shares of the company’s stock worth $123,158,000 after buying an additional 38,676 shares during the period. Systematic Financial Management LP raised its position in shares of Amsurg Corp. by 12.5% in the second quarter. Systematic Financial Management LP now owns 1,351,163 shares of the company’s stock worth $104,769,000 after buying an additional 150,381 shares during the period. Finally, Goldman Sachs Group Inc. raised its position in shares of Amsurg Corp. by 33.5% in the first quarter. Goldman Sachs Group Inc. now owns 1,028,828 shares of the company’s stock worth $76,751,000 after buying an additional 257,891 shares during the period. Hedge funds and other institutional investors own 98.42% of the company’s stock.
About Amsurg Corp.
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Receive News & Stock Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related stocks with our FREE daily email newsletter.